4//SEC Filing
Adamis Pharmaceuticals Corp 4
Accession 0001387131-16-005715
CIK 0000887247operating
Filed
May 26, 8:00 PM ET
Accepted
May 27, 5:27 PM ET
Size
5.6 KB
Accession
0001387131-16-005715
Insider Transaction Report
Form 4
Glover Eddie Wabern
CEO of U.S. Compounding, Inc.
Transactions
- Award
Employee Stock Option (right to buy)
2016-05-25+70,000→ 70,000 totalExercise: $8.46Exp: 2026-05-25→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable as to one-sixth of the option shares on the six-month anniversary of the grant date, and thereafter as to 1/36 of the option shares on each monthly anniversary of the grant date commencing with the seven-month anniversary of the grant date.
Documents
Issuer
Adamis Pharmaceuticals Corp
CIK 0000887247
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000887247
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 5:27 PM ET
- Size
- 5.6 KB